Smith Julie, a director at Exelixis, Inc. ($EXEL), sold $4.7 million worth of company shares in three open market transactions over the last year. Her most recent sale occurred on February 18, 2026. These sales rank her 2,028th among 11,678 insiders in our database by total value sold, below the average of $8.6 million across about 6.4 transactions per insider. Smith Julie made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | M | Common Stock | 42422 | $18.19 | 63,012.0000 | 281,863,000 | 206.03% | 0.02% |
| Feb. 18, 2026 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | M | Option (right to buy) | 20030 | $0.00 | 0.0000 | 281,863,000 | 100.00% | 0.01% |
| Feb. 18, 2026 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | M | Option (right to buy) | 44087 | $0.00 | 0.0000 | 281,863,000 | 100.00% | 0.02% |
| Feb. 17, 2026 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | M | Option (right to buy) | 42422 | $0.00 | 0.0000 | 281,863,000 | 100.00% | 0.02% |
| Feb. 18, 2026 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | S | Common Stock | 20030 | $44.30 | 20,590.0000 | 281,863,000 | 49.31% | 0.01% |
| Feb. 18, 2026 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | M | Common Stock | 20030 | $21.69 | 40,620.0000 | 281,863,000 | 97.28% | 0.01% |
| Feb. 18, 2026 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | S | Common Stock | 44087 | $44.50 | 20,590.0000 | 281,863,000 | 68.16% | 0.02% |
| Feb. 18, 2026 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | M | Common Stock | 44087 | $19.39 | 64,677.0000 | 281,863,000 | 214.12% | 0.02% |
| Feb. 17, 2026 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | S | Common Stock | 42422 | $43.33 | 20,590.0000 | 281,863,000 | 67.32% | 0.02% |
| June 3, 2025 | Stoke Therapeutics, Inc. | $STOK | Smith Julie | Not found | A | Director Stock Option (Right to Buy) | 29747 | $0.00 | 29,747.0000 | 54,008,883 | 9999.99% | 0.06% |
| May 29, 2025 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | A | Common Stock | 9812 | $0.00 | 20,590.0000 | 296,132,000 | 91.04% | 0.00% |
| Feb. 28, 2025 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | M | Option (right to buy) | 19294 | $0.00 | 0.0000 | 296,132,000 | 100.00% | 0.01% |
| Feb. 27, 2025 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | M | Option (right to buy) | 31167 | $0.00 | 0.0000 | 296,132,000 | 100.00% | 0.01% |
| Feb. 28, 2025 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | S | Common Stock | 19294 | $37.62 | 10,778.0000 | 296,132,000 | 64.16% | 0.01% |
| Feb. 28, 2025 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | M | Common Stock | 19294 | $19.77 | 30,072.0000 | 296,132,000 | 179.01% | 0.01% |
| Feb. 27, 2025 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | S | Common Stock | 54514 | $38.13 | 10,778.0000 | 296,132,000 | 83.49% | 0.02% |
| Feb. 27, 2025 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | M | Common Stock | 23347 | $19.77 | 65,292.0000 | 296,132,000 | 55.66% | 0.01% |
| Feb. 27, 2025 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | M | Common Stock | 31167 | $20.50 | 41,945.0000 | 296,132,000 | 289.17% | 0.01% |
| Feb. 27, 2025 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | M | Option (right to buy) | 23347 | $0.00 | 19,294.0000 | 296,132,000 | 54.75% | 0.01% |
| Aug. 13, 2024 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | J | Common Stock | 4682 | $0.00 | 10,778.0000 | 321,464,000 | 30.28% | 0.00% |
| June 5, 2024 | Stoke Therapeutics, Inc. | $STOK | Smith Julie | Not found | A | Director Stock Option (Right to Buy) | 7639 | $0.00 | 7,639.0000 | 43,994,862 | 9999.99% | 0.02% |
| May 31, 2024 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | A | Common Stock | 10015 | $0.00 | 15,460.0000 | 321,464,000 | 183.93% | 0.00% |
| May 31, 2024 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | A | Option (right to buy) | 20030 | $0.00 | 20,030.0000 | 321,464,000 | 9999.99% | 0.01% |
| May 21, 2024 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | S | Common Stock | 27280 | $21.12 | 5,445.0000 | 321,464,000 | 83.36% | 0.01% |
| June 1, 2023 | EXELIXIS, INC. | $EXEL | Smith Julie | Director | A | Option (right to buy) | 44087 | $0.00 | 44,087.0000 | 324,556,000 | 9999.99% | 0.01% |